Pyrrolopyrimidine c-Src inhibitors reduce growth, adhesion, motility and invasion of prostate cancer cells in vitro
Full Text Available
PII: S0959-8049(03)00394-0
doi:10.1016/S0959-8049(03)00394-0
© 2003 Elsevier Science Ltd. All rights reserved.
PII: S0959-8049(03)00394-0
doi:10.1016/S0959-8049(03)00394-0
© 2003 Elsevier Science Ltd. All rights reserved.